- Home
- TANH vs XRTX Comparison
TANH vs XRTX Comparison
Compare TANH & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TANH
- XRTX
- Stock Information
- Founded
- TANH 2001
- XRTX 2011
- Country
- TANH China
- XRTX Canada
- Employees
- TANH N/A
- XRTX N/A
- Industry
- TANH
- XRTX Pharmaceuticals and Biotechnology
- Sector
- TANH
- XRTX Health Care
- Exchange
- TANH Nasdaq
- XRTX Nasdaq
- Market Cap
- TANH 3.5M
- XRTX 3.0M
- IPO Year
- TANH 2015
- XRTX N/A
- Fundamental
- Price
- TANH $2.29
- XRTX $1.08
- Analyst Decision
- TANH
- XRTX
- Analyst Count
- TANH 0
- XRTX 0
- Target Price
- TANH N/A
- XRTX N/A
- AVG Volume (30 Days)
- TANH 49.7K
- XRTX 43.2K
- Earning Date
- TANH 06-10-2025
- XRTX 05-16-2025
- Dividend Yield
- TANH N/A
- XRTX N/A
- EPS Growth
- TANH N/A
- XRTX N/A
- EPS
- TANH 38.81
- XRTX N/A
- Revenue
- TANH $49,103,298.00
- XRTX N/A
- Revenue This Year
- TANH N/A
- XRTX N/A
- Revenue Next Year
- TANH N/A
- XRTX N/A
- P/E Ratio
- TANH $0.06
- XRTX N/A
- Revenue Growth
- TANH 6.14
- XRTX N/A
- 52 Week Low
- TANH $1.45
- XRTX $0.80
- 52 Week High
- TANH $63.60
- XRTX $3.24
- Technical
- Relative Strength Index (RSI)
- TANH 52.65
- XRTX 59.65
- Support Level
- TANH $1.87
- XRTX $0.82
- Resistance Level
- TANH $2.15
- XRTX $1.13
- Average True Range (ATR)
- TANH 0.20
- XRTX 0.10
- MACD
- TANH 0.10
- XRTX 0.03
- Stochastic Oscillator
- TANH 96.30
- XRTX 71.65
About TANH Tantech Holdings Ltd.
Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company through its subsidiaries is engaged in the production and distribution of household products along with a trading business which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments; the Consumer Product segment, and the Electric Vehicle (EV) segment.
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.